IR-Med Inc. announced the appointment of Richard Serbin, Esq. to its Advisory Board as the Company prepares to file for regulatory listing of its PressureSafe? device with the U.S. Food & Drug Administration (FDA) with the intent of a subsequent market launch in the U.S. Mr. Serbin was the Chief FDA Counsel for Revlon Corporation and Johnson & Johnson Corporation.

He held senior management roles at Johnson & Johnson and served on the Board of Directors of numerous Johnson & Johnson subsidiary companies including Ethicon, Ortho, Johnson & Johnson Consumer Products, Pittman-Moore, McNeil and Johnson & Johnson Development Corporation, that company?s strategic venture capital division. His broader experience includes serving on the boards of numerous other companies involved in biotechnology, dermatology, veterinary medicine, female healthcare, medical devices, photodynamic therapy, surgical and consumer products. For more than a decade, Mr. Serbin has served as a Senior Advisor to the Swedish American Life Science Summit (SALSS), the leading invitation healthcare summit, held annually in Stockholm, Sweden.

Currently, he is Managing Director of Platform Health Ventures, a healthcare strategic and tactical consulting group. He formerly served as Chief Operating Officer of the Gorlin Companies and he served as President of Bradley Pharmaceuticals. He has a Bachelor of Science and a Bachelor of Pharmacy from Rutgers University and Rutgers University College of Pharmacy, a J.D. degree from Seton Hall Law School, and a Master?s Degree in Trade Regulations and Law from New York University Law School.